FDA Asks Court for 18-Month Pause in Key COVID-19 Vaccine Safety Data Cases
The FDA is requesting an 18-month suspension of litigation to delay the release of critical safety data regarding COVID-19 vaccines, citing overwhelming workloads in specific branches. By invoking "exceptional circumstances," the agency argues that unprecedented volumes of records and FOIA requests exceed current resource capacities, thereby justifying a pause to prevent administrative collapse. Opposing groups contend that these delays stem from strategic understaffing rather than genuine capacity limits, arguing that overall agency request volumes have not increased proportionally. They assert that the burden is artificially concentrated in one unit and that adequate funding should have been allocated to ensure transparency, suggesting the backlog is a result of internal management choices rather than external pressure. This dispute is highly relevant to open data initiatives as it highlights the tension between institutional transparency and administrative efficiency in handling sensitive health information. The outcome will set a precedent for how government agencies balance FOIA obligations with operational constraints, directly impacting public access to verified safety data and the accountability of regulatory bodies.
Source: theepochtimes.comPublished on 2023-10-14
Related news
- Inai ordena revelar presupuesto millonario para refinería Dos Bocas en Tabasco | Revista Punto de Vista
- Kenyan Firm Engages FBI to Strengthen Its Position in Dispute with X Corp
- CC advierte tintes políticos en boleta censal porque busca muertes desde la crisis política del 2019
- Plantean ley para que jubilación de funcionarios públicos sea a los 75 años - Política - ABC Color